AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-37233936_ITM" title="Facts and information about RANBAXY TO LAUNCH DAIICHI'S ANTI-HYPERSENSITIVE DRUG IN INDIA.">RANBAXY TO LAUNCH DAIICHI'S ANTI-HYPERSENSITIVE DRUG IN INDIA.</a>
Close
Set up an RSS feed that alerts you when new articles from AsiaPulse News are available.
Frequently asked questions about RSS feeds
RANBAXY TO LAUNCH DAIICHI'S ANTI-HYPERSENSITIVE DRUG IN INDIA.
NEW DELHI, April 1 Asia Pulse - Ranbaxy Laboratories (BSE:500359) will launch in India an anti-hypertensive drug, Olvance -- the first product from its Japanese parent Daiichi Sankyo's (TSE:4568) portfolio to be introduced through it.
Olvance (Olmesartan Medoxomil) was originally discovered by Daiichi Sankyo and its introduction in the country follows a licensing agreement between the two companies authorising the Gurgaon-based firm to promote and market the drug in India, the two companies said in a statement.
The launch of Olvance marks the beginning of a productive engagement that will harness the ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- CORPORATE: Ranbaxy to market Daiichi Sankyo's BP drug in India.
- News wire article from: Business Line April 1, 2009 700+ words
...the drug - Olvance - in India. This is first drug from the Daiichi Sankyo's stable to be marketed in India after it acquired a controlling...product introductions, in India, through Ranbaxy." Meanwhile, Daiichi Sankyo said that it was planning...
- Ranbaxy to launch Daiichi Sankyo's innovative antihypertensive, Olvance, in...
- News wire article from: Chemical Business Newsbase March 31, 2009 700+ words
...was originally discovered by Daiichi Sankyo. This follows a licensing agreement...promote and market the drug in India. A top Daiichi Sankyo official noted that the move...innovative product introductions in India through Ranbaxy. The clinical...
- Ranbaxy to Market Daiichi Sankyo's Olvance in India.
- News wire article from: Chemical Business Newsbase May 31, 2009 700+ words
...Laboratories is all set to introduce Daiichi Sankyo's Olvance (Olmesartan medoxomil), an anti-hypertensive drug in India, consequent upon licensing agreement between Daiichi Sankyo and Ranbaxy for selling and advertising...
- Ranbaxy to join Daiichi Sankyo to market olmestran in India.
- News wire article from: Chemical Business Newsbase January 26, 2009 700+ words
Daiichi Sankyo's first collaborative project with Ranbaxy Laboratories in India is the marketing of Daiichi's mainstay...antagonist). Ranbaxy was purchased by Daiichi Sankyo in 2008. The drug was launched in Jun...
- RANBAXY TO MARKET DAIICHI SANKYO'S BP DRUG IN INDIA (the two companies have...
- Magazine article from: India Business Insight April 1, 2009 700+ words
Ranbaxy Laboratories Ltd will market the blood pressure drug, Olvance, of Daiichi Sankyo in India. The two companies have signed a licensing agreement to market the drug. Daiichi Sankyo has acquired a controlling stake in Ranbaxy.
- DAIICHI SANKYO DEAL AMONG 24 FDI PROPOSALS CLEARED (Black & Decker cleared for...
- Magazine article from: India Business Insight August 5, 2008 700+ words
The Government of India cleared a total of 24 foreign direct...Aug 2008, including the proposal of Daiichi Sankyo of Japan to acquire shareholding in...clearance for setting up a company in India for manufacturing and this involves...
- Daiichi Sankyo and Ranbaxy Announce Reconstitution of Ranbaxy Executive...
- Newspaper article from: Biotech Week June 10, 2009 700+ words
...central focus of Daiichi Sankyo's research and...Laboratories Limited, India's largest pharmaceutical...a subsidiary of Daiichi Sankyo Company, Ltd. Keywords: Daiichi Sankyo Co., Ltd., Health...Other Health, India, Acquisitions...
- DAIICHI SANKYO AND RANBAXY CONFIRM DEAL IS BINDING AND FINAL.
- News wire article from: AsiaPulse News July 17, 2008 700+ words
...Company, Limited Daiichi Sankyo Company, Limited...Laboratories Limited, India's largest pharmaceutical...countries. Source: Daiichi Sankyo Company, Limited Contact: Daiichi Sankyo Co., Ltd. 3...Haryana122001, India Ramesh L. Adige...
- Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market...
- Press release article from: PR Newswire July 17, 2008 700+ words
...and NEW DELHI, India, July 17 /PRNewswire...stock market, Daiichi Sankyo Company, Limited...countries. Contact: Daiichi Sankyo Co., Ltd. 3...Haryana122001, India Ramesh L. Adige...Communications Department, Daiichi Sankyo Company, Limited...
- Daiichi plans to buy Ranbaxy, but counteroffer may emerge.(RX/News)(Daiichi...
- Magazine article from: Chain Drug Review June 30, 2008 700+ words
...drug manufacturer Daiichi Sankyo Co. says it will...majority control of India's Ranbaxy Laboratories...impressive move by Daiichi Sankyo into the generic...Ranbaxy is one of India's largest drug...deal would give Daiichi Sankyo operations in 60...
Source: HighBeam Research, RANBAXY TO LAUNCH DAIICHI'S ANTI-HYPERSENSITIVE DRUG IN INDIA.